Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Dunseth Myers currently holds 35,004 shares of Cascadian Therapeutics, Inc. (CASC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Dunseth Myers has been a net buyer of CASC stock. They have purchased $475.5K and sold $0 worth of shares.
Scott Dunseth Myers's most recent insider trade was on Aug 22, 2025, when they purchased 3,800 shares at $10.82 per share.
Scott Dunseth Myers serves as Executive at Cascadian Therapeutics, Inc. (CASC). They have executed 28 insider transactions totaling $475.5K over their tenure at the company.
Scott Dunseth Myers holds the position of Executive at Cascadian Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Scott Dunseth Myers has shown a buying trading pattern, with $475.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Scott Dunseth Myers was on Mar 13, 2023, when they purchased $160.3K worth of VRDN shares. This transaction involved 5,500 shares at $29.15 per share.
Scott Dunseth Myers currently owns 35,004 shares of Cascadian Therapeutics, Inc. (CASC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Dunseth Myers's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Dunseth Myers has 28 Form 4 filings on record as an insider at Cascadian Therapeutics, Inc..
Set alerts for Scott Dunseth Myers and 40,000+ other insiders.